Search research articles
Contact Us
Filters
Showing results (151-160 of 513) with videos related to
Page
of 52
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer
Kangkook Lee, Youjin Kim, Hyun Ae Jung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 19, 2018
Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication
Hansang Lee, Ho Yun Lee, Jong-Mu Sun, et al.
Japanese Journal of Clinical Oncology
|
February 22, 2020
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice
Jiyun Lee, Bo Mi Ku, Joon Ho Shim, et al.
Frontiers in Immunology
|
January 20, 2023
Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors
Changhee Park, Dong Young Jeong, Yeonu Choi, et al.
European Journal of Immunology
|
January 28, 2021
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer
Bo Mi Ku, Youjin Kim, Kyoung Young Lee, et al.
Translational Oncology
|
December 16, 2014
Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status
Jae Kyung Myung, Hwa Jin Cho, Hanna Kim, et al.
Translational Cancer Research
|
July 11, 2024
Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancer
Ye Ji Jung, Joonghyun Ahn, Sehhoon Park, et al.
Frontiers in Medicine
|
October 13, 2022
Metabolic parameters on baseline <sup>18</sup>F-FDG PET/CT are potential predictive biomarkers for immunotherapy in patients with head and neck squamous cell carcinoma
Hye Ryeong Kwon, Junhun Cho, Sehhoon Park, et al.
Clinical Lung Cancer
|
December 29, 2015
Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non-Small-Cell Lung Cancer
Jae Joon Han, Dong-Wan Kim, Jaemoon Koh, et al.
Journal of Medical Genetics
|
March 29, 2017
Comprehensive somatic genome alterations of urachal carcinoma
Seungchul Lee, Jingu Lee, Sung Hoon Sim, et al.
Page
of 52
Search research articles
Search
Showing results (151-160 of 513) with videos related to
Sort By:
Page
of 52
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer
Kangkook Lee, Youjin Kim, Hyun Ae Jung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 19, 2018
Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication
Hansang Lee, Ho Yun Lee, Jong-Mu Sun, et al.
Japanese Journal of Clinical Oncology
|
February 22, 2020
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice
Jiyun Lee, Bo Mi Ku, Joon Ho Shim, et al.
Frontiers in Immunology
|
January 20, 2023
Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors
Changhee Park, Dong Young Jeong, Yeonu Choi, et al.
European Journal of Immunology
|
January 28, 2021
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer
Bo Mi Ku, Youjin Kim, Kyoung Young Lee, et al.
Translational Oncology
|
December 16, 2014
Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status
Jae Kyung Myung, Hwa Jin Cho, Hanna Kim, et al.
Translational Cancer Research
|
July 11, 2024
Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancer
Ye Ji Jung, Joonghyun Ahn, Sehhoon Park, et al.
Frontiers in Medicine
|
October 13, 2022
Metabolic parameters on baseline <sup>18</sup>F-FDG PET/CT are potential predictive biomarkers for immunotherapy in patients with head and neck squamous cell carcinoma
Hye Ryeong Kwon, Junhun Cho, Sehhoon Park, et al.
Clinical Lung Cancer
|
December 29, 2015
Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non-Small-Cell Lung Cancer
Jae Joon Han, Dong-Wan Kim, Jaemoon Koh, et al.
Journal of Medical Genetics
|
March 29, 2017
Comprehensive somatic genome alterations of urachal carcinoma
Seungchul Lee, Jingu Lee, Sung Hoon Sim, et al.
Page
of 52